Literature DB >> 30850038

What's New in Melanoma.

Giselle Prado1, Ryan M Svoboda2, Darrell S Rigel3.   

Abstract

Melanoma is rapidly evolving because of advances in noninvasive diagnosis, targeted therapies, and improved prognostic methods. This article discusses what is new in melanoma risk factors, prevention, clinical management, and targeted treatment. The incidence continues to increase worldwide, whereas mortality is steadily improving. This trend reinforces the importance of dermatologists comprehensively understanding all aspects of melanoma. Further research is needed to continue making a material impact on outcomes for patients.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diagnosis; Genomics; Management; Melanoma epidemiology; Prognosis; Risk factors

Mesh：

Substances：

Year:  2019        PMID： 30850038     DOI： 10.1016/j.det.2018.12.005

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN： 0733-8635            Impact factor:   3.478


  14 in total

1.  Formulation, Cellular Uptake and Cytotoxicity of Thymoquinone-Loaded PLGA Nanoparticles in Malignant Melanoma Cancer Cells.

Authors:  Wisam Nabeel Ibrahim; Luqman Muizzuddin Bin Mohd Rosli; Abd Almonem Doolaanea
Journal:  Int J Nanomedicine       Date:  2020-10-20

2.  Incidence and Survival Rates of Cutaneous Melanoma in South Korea Using Nationwide Health Insurance Claims Data.

Authors:  TaeHo Kim; Siyeong Yoon; Dong-Eun Shin; Sang Cheol Lee; Jisu Oh; So-Young Lee; Do Kyung Kim; Segi Kim; Bosung Jung; Minsup Kim; Soonchul Lee
Journal:  Cancer Res Treat       Date:  2021-09-30       Impact factor: 5.036

3.  Curcumin plays a synergistic role in combination with HSV-TK/GCV in inhibiting growth of murine B16 melanoma cells and melanoma xenografts.

Authors:  Hong Li; Haiyan Du; Guangxian Zhang; Yingya Wu; Pengxiang Qiu; Jingjing Liu; Jing Guo; Xijuan Liu; Lingling Sun; Biaoyan Du; Yuhui Tan
Journal:  PeerJ       Date:  2019-09-20       Impact factor: 2.984

4.  Melanoma Following In Vitro Fertilization: Co-incident or Coincidence?

Authors:  Philip R Cohen; Christof P Erickson; Brooke R Sateesh; Nathan S Uebelhoer; Antoanella Calame
Journal:  Cureus       Date:  2019-06-07

5.  Patients with melanoma of unknown primary show better outcome under immune checkpoint inhibitor therapy than patients with known primary: preliminary results.

Authors:  Thilo Gambichler; Maria Chatzipantazi; Ulrike Schröter; E Stockfleth; Cansu Gedik
Journal:  Oncoimmunology       Date:  2019-10-21       Impact factor: 8.110

6.  Testing Lab-on-a-Chip Technology for Culturing Human Melanoma Cells under Simulated Microgravity.

Authors:  Dawid Przystupski; Agata Górska; Olga Michel; Agnieszka Podwin; Patrycja Śniadek; Radosław Łapczyński; Jolanta Saczko; Julita Kulbacka
Journal:  Cancers (Basel)       Date:  2021-01-22       Impact factor: 6.639

7.  Cutaneous melanoma: cost of illness under Brazilian health system perspectives.

Authors:  Cassia Rita Pereira da Veiga; Claudimar Pereira da Veiga; Alceu Souza; Alberto Julius Alves Wainstein; Andreia Cristina de Melo; Ana Paula Drummond-Lage
Journal:  BMC Health Serv Res       Date:  2021-03-29       Impact factor: 2.655

8.  uPAR-expressing melanoma exosomes promote angiogenesis by VE-Cadherin, EGFR and uPAR overexpression and rise of ERK1,2 signaling in endothelial cells.

Authors:  Alessio Biagioni; Anna Laurenzana; Beatrice Menicacci; Silvia Peppicelli; Elena Andreucci; Francesca Bianchini; Daniele Guasti; Paolo Paoli; Simona Serratì; Alessandra Mocali; Lido Calorini; Mario Del Rosso; Gabriella Fibbi; Anastasia Chillà; Francesca Margheri
Journal:  Cell Mol Life Sci       Date:  2020-11-25       Impact factor: 9.261

9.  Assessment of Betulinic Acid Cytotoxicity and Mitochondrial Metabolism Impairment in a Human Melanoma Cell Line.

Authors:  Dorina Coricovac; Cristina Adriana Dehelean; Iulia Pinzaru; Alexandra Mioc; Oana-Maria Aburel; Ioana Macasoi; George Andrei Draghici; Crina Petean; Codruta Soica; Madalina Boruga; Brigitha Vlaicu; Mirela Danina Muntean
Journal:  Int J Mol Sci       Date:  2021-05-04       Impact factor: 5.923

10.  Tre2-Bub2-Cdc16 Family Proteins Based Nomogram Serve as a Promising Prognosis Predicting Model for Melanoma.

Authors:  Ling Tang; Cong Peng; Su-Si Zhu; Zhe Zhou; Han Liu; Quan Cheng; Xiang Chen; Xiao-Ping Chen
Journal:  Front Oncol       Date:  2020-10-28       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.